Clinical Trials Logo

Clinical Trial Summary

This is a non-randomized feasibility study of endothelial function, exercise capacity, and outcome following pre-left ventricular assist device (LVAD)therapy and cardiac transplant.

The study period will be 5 years, with 20 patients to be enrolled. The investigators anticipate that 15 patients will survive to complete the one year follow up period.(the published survival rate of LVAD is 75% in one year). 10 patients are anticipated to undergo cardiac transplant within 3 years of initial enrollment and they are followed until their 2nd annual post transplant invasive evaluation.

Markers of endothelial function will be studied to permit comparison with selected clinical outcomes. The hypothesis is that the endothelial functions will be altered after implantation of LVAD then before its implantation, both acutely and chronically, and this may affect the exercise capacity, quality of life and occurrence of cardiac allograft vasculopathy post cardiac transplantation.


Clinical Trial Description

This is a non-randomized, feasibility study of endothelial function, exercise capacity, and outcome following pre-LVAD patients through LVAD therapy and cardiac transplantation.

The study period will be 5 years. It is anticipated that 20 patients will be enrolled and 15 will survive (published survival estimate following LVAD is approximately 75% at one year) to complete the one-year follow-up period. 10 patients are anticipated to undergo heart transplant within 3 years of initial enrollment and they will be followed until their 2nd annual post-transplant invasive evaluation. ;


Study Design

Observational Model: Case Control, Time Perspective: Prospective


Related Conditions & MeSH terms


NCT number NCT01233037
Study type Observational
Source University of Minnesota - Clinical and Translational Science Institute
Contact
Status Completed
Phase N/A
Start date October 2010
Completion date June 2016

See also
  Status Clinical Trial Phase
Completed NCT00731926 - Effect of Antioxidant on Endurance Performance in Healthy Men Phase 2/Phase 3
Completed NCT06010459 - Reference Values for the Six-minute Pegboard and Ring Test in Healthy Adults in Turkey
Recruiting NCT01016431 - Effects of Atrial Rate-adaptive Pacing on Exercise Capacity in Patients With Chronic Heart Failure Complicated by Chronotropic Incompetence Phase 4
Completed NCT03849300 - Impacts of Aquatic vs Land Walking on Vascular Health and Exercise Tolerance in Patients With Peripheral Artery Disease N/A
Not yet recruiting NCT03866915 - Validity of Aortic Pulse Wave Velocity in Predicting the 6- Minute Walking Test Before Major Non-cardiac Surgery
Completed NCT04734743 - Muscle Strength, Functional Capacity, Respiratory Function and Quality Of Life In Cystic Fibrosis Patients N/A
Completed NCT04767477 - Telerehabilitation and Face-to-face Rehabilitation on COVID-19 Survivors N/A
Recruiting NCT02102321 - Does Treating Hookworm Improve Productivity of Small Subsistence Farmers N/A
Completed NCT02779972 - Age Related Changes in Cardiac Physiology as a Predictor of Exercise Tolerance N/A
Enrolling by invitation NCT05608603 - Diagnostics of Coronavirus Disease 2019 Cardiovascular Complications
Completed NCT03190304 - The Effect of Neprilysin (LCZ696) on Exercise Tolerance in Patients With Heart Failure Phase 4
Completed NCT03936348 - Effects of an Exercise Rehabilitation Programme With a Nasal Inspiratory Restriction Device in COPD Patients N/A
Completed NCT04089410 - Direct and Cross Effects of Adaptation to Systemic Hyperthermia: Impact on Quality of Life, Neurohormonal and Psychophysiological Human Status N/A
Recruiting NCT05379608 - Intermittent Hypoxic-hyperoxic Training in Patients With Cardiovascular Pathology After COVID-19 Infection. N/A
Completed NCT01418248 - Study of Exercise and Heart Function in Patients With Heart Failure and Pulmonary Vascular Disease N/A